Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study

Background: Type 2 diabetes mellitus (T2DM) and inflammatory bowel disease (IBD) have been associated, according to various epidemiological research. This study uses Mendelian randomization (MR) to investigate the causal link between T2DM and IBD.Methods: To investigate the causal relationship betwe...

Full description

Bibliographic Details
Main Authors: Ling-tong Tang, Lei Feng, Hui-ying Cao, Rui Shi, Bei-bei Luo, Yan-bi Zhang, Yan-mei Liu, Jian Zhang, Shuang-yue Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2024.1325401/full
_version_ 1827349018547585024
author Ling-tong Tang
Lei Feng
Hui-ying Cao
Rui Shi
Bei-bei Luo
Yan-bi Zhang
Yan-mei Liu
Jian Zhang
Shuang-yue Li
author_facet Ling-tong Tang
Lei Feng
Hui-ying Cao
Rui Shi
Bei-bei Luo
Yan-bi Zhang
Yan-mei Liu
Jian Zhang
Shuang-yue Li
author_sort Ling-tong Tang
collection DOAJ
description Background: Type 2 diabetes mellitus (T2DM) and inflammatory bowel disease (IBD) have been associated, according to various epidemiological research. This study uses Mendelian randomization (MR) to investigate the causal link between T2DM and IBD.Methods: To investigate the causal relationship between IBD and T2DM risk using European population data from the genome-wide association study (GWAS) summary datasets, we constructed a two-sample MR study to evaluate the genetically predicted impacts of liability towards IBD outcomes on T2DM risk. As instrumental variables (IVs), we chose 26 single nucleotide polymorphisms (SNPs) associated with IBD exposure data. The European T2DM GWAS data was obtained from the IEU OpenGWAS Project database, which contains 298,957 cases as the outcome data. The causal relationship between T2DM and IBD using a reverse MR analysis was also performed.Results: The two-sample MR analysis, with the Bonferroni adjustment for multiple testing, revealed that T2DM risk in Europeans is unaffected by their IBD liability (odds ratio (OR): 0.950–1.066, 95% confidence interval (CI): 0.885–1.019, p = 0.152–0.926). The effects of liability to T2DM on IBD were not supported by the reverse MR analysis either (OR: 0.739–1.131, 95% confidence interval (CI): 0.651–1.100, p = 0.058–0.832). MR analysis of IBS on T2DM also have no significant causal relationship (OR: 0.003–1.007, 95% confidence interval (CI): 1.013–5.791, p = 0.069–0.790). FUMA precisely mapped 22 protein-coding genes utilizing significant SNPs of T2DM acquired from GWAS.Conclusion: The MR study showed that the existing evidence did not support the significant causal effect of IBD on T2DM, nor did it support the causal impact of T2DM on IBD.
first_indexed 2024-03-08T00:22:04Z
format Article
id doaj.art-84ead373ab0647f2b219f0e8fb105863
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-08T00:22:04Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-84ead373ab0647f2b219f0e8fb1058632024-02-16T04:51:36ZengFrontiers Media S.A.Frontiers in Genetics1664-80212024-02-011510.3389/fgene.2024.13254011325401Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization studyLing-tong Tang0Lei Feng1Hui-ying Cao2Rui Shi3Bei-bei Luo4Yan-bi Zhang5Yan-mei Liu6Jian Zhang7Shuang-yue Li8Department of Clinical Laboratory, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Sixth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Sixth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Sixth Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, ChinaDepartment of Clinical Laboratory, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, ChinaBackground: Type 2 diabetes mellitus (T2DM) and inflammatory bowel disease (IBD) have been associated, according to various epidemiological research. This study uses Mendelian randomization (MR) to investigate the causal link between T2DM and IBD.Methods: To investigate the causal relationship between IBD and T2DM risk using European population data from the genome-wide association study (GWAS) summary datasets, we constructed a two-sample MR study to evaluate the genetically predicted impacts of liability towards IBD outcomes on T2DM risk. As instrumental variables (IVs), we chose 26 single nucleotide polymorphisms (SNPs) associated with IBD exposure data. The European T2DM GWAS data was obtained from the IEU OpenGWAS Project database, which contains 298,957 cases as the outcome data. The causal relationship between T2DM and IBD using a reverse MR analysis was also performed.Results: The two-sample MR analysis, with the Bonferroni adjustment for multiple testing, revealed that T2DM risk in Europeans is unaffected by their IBD liability (odds ratio (OR): 0.950–1.066, 95% confidence interval (CI): 0.885–1.019, p = 0.152–0.926). The effects of liability to T2DM on IBD were not supported by the reverse MR analysis either (OR: 0.739–1.131, 95% confidence interval (CI): 0.651–1.100, p = 0.058–0.832). MR analysis of IBS on T2DM also have no significant causal relationship (OR: 0.003–1.007, 95% confidence interval (CI): 1.013–5.791, p = 0.069–0.790). FUMA precisely mapped 22 protein-coding genes utilizing significant SNPs of T2DM acquired from GWAS.Conclusion: The MR study showed that the existing evidence did not support the significant causal effect of IBD on T2DM, nor did it support the causal impact of T2DM on IBD.https://www.frontiersin.org/articles/10.3389/fgene.2024.1325401/fullMendelian randomizationtype 2 diabetes mellitusinflammatory bowel diseaseirritable bowel syndromecausal relationship
spellingShingle Ling-tong Tang
Lei Feng
Hui-ying Cao
Rui Shi
Bei-bei Luo
Yan-bi Zhang
Yan-mei Liu
Jian Zhang
Shuang-yue Li
Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study
Frontiers in Genetics
Mendelian randomization
type 2 diabetes mellitus
inflammatory bowel disease
irritable bowel syndrome
causal relationship
title Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study
title_full Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study
title_fullStr Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study
title_full_unstemmed Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study
title_short Investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus: a Mendelian randomization study
title_sort investigation of the causal relationship between inflammatory bowel disease and type 2 diabetes mellitus a mendelian randomization study
topic Mendelian randomization
type 2 diabetes mellitus
inflammatory bowel disease
irritable bowel syndrome
causal relationship
url https://www.frontiersin.org/articles/10.3389/fgene.2024.1325401/full
work_keys_str_mv AT lingtongtang investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT leifeng investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT huiyingcao investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT ruishi investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT beibeiluo investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT yanbizhang investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT yanmeiliu investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT jianzhang investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy
AT shuangyueli investigationofthecausalrelationshipbetweeninflammatoryboweldiseaseandtype2diabetesmellitusamendelianrandomizationstudy